A detailed history of Neuberger Berman Group LLC transactions in Organon & Co. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 93,409 shares of OGN stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93,409
Holding current value
$1.93 Million
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.78 - $18.8 $1.29 Million - $1.76 Million
93,409 New
93,409 $1.76 Million
Q4 2023

Feb 09, 2024

BUY
$10.95 - $17.32 $300,413 - $475,174
27,435 Added 38.08%
99,489 $1.43 Million
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $90,913 - $130,259
-5,480 Reduced 7.07%
72,054 $1.25 Million
Q2 2023

Aug 11, 2023

SELL
$19.27 - $24.63 $1.43 Million - $1.83 Million
-74,452 Reduced 48.99%
77,534 $1.61 Million
Q1 2023

May 12, 2023

SELL
$21.42 - $32.08 $32,644 - $48,889
-1,524 Reduced 0.99%
151,986 $3.57 Million
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $5.35 Million - $6.57 Million
-229,571 Reduced 59.93%
153,510 $4.29 Million
Q3 2022

Nov 15, 2022

BUY
$23.4 - $34.25 $29,624 - $43,360
1,266 Added 0.33%
383,081 $8.96 Million
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $596,632 - $733,070
-18,845 Reduced 4.7%
381,815 $12.9 Million
Q1 2022

May 13, 2022

BUY
$30.45 - $39.36 $54,870 - $70,926
1,802 Added 0.45%
400,660 $13.9 Million
Q4 2021

Feb 11, 2022

BUY
$28.67 - $37.13 $3.44 Million - $4.45 Million
119,850 Added 42.96%
398,858 $12.1 Million
Q3 2021

Nov 12, 2021

BUY
$28.63 - $35.64 $1.76 Million - $2.19 Million
61,538 Added 28.3%
279,008 $9.06 Million
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $6.19 Million - $8.26 Million
217,470 New
217,470 $6.51 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.26B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.